Stock listing
1YR Stock Price, News, Filings & Events — Immunovia Ab
Selected listing: 1YR · MUN · EUR · DE
This page tracks Immunovia Ab's 1YR:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 1YR:MUN. 1YR:MUN is the stock-level entry point for investors researching Immunovia Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 1YR:MUN
- Asset type
- Stock
- Market cap
- $5.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- MUN
- Currency
- EUR
Immunovia Ab 1YR:MUN stock context
This page tracks Immunovia Ab's 1YR:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 1YR:MUN. 1YR:MUN is the stock-level entry point for investors researching Immunovia Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Immunovia Ab
Immunovia Publishes Interim Report for April-June 2026
August 6, 2026
Immunovia announces new performance data for PancreaSure ahead of upcoming application for Medicare coverage
June 15, 2026
Immunovia publishes final AFFIRM study results in Journal of Clinical Oncology confirming strong diagnostic performance of PancreaSure
June 10, 2026
Immunovia Publishes Interim Report for January-March 2026
May 7, 2026
Immunovia launches ASSURE registry to evaluate real-world clinical impact of PancreaSure in high-risk pancreatic cancer surveillance
May 5, 2026
Immunovia Ab earnings calls
Immunovia AB (IMMNOV) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Immunovia AB (IMMNOV) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Immunovia AB (IMMNOV) Q4 2025 Earnings Call
February 24, 2026 · Replay with transcript and chapters
Immunovia AB (IMMNOV) Q3 2025 Earnings Call
November 26, 2025 · Replay with transcript and chapters
Immunovia AB (IMMNOV) Q2 2025 Earnings Call
August 28, 2025 · Replay with transcript and chapters
Immunovia AB (IMMNOV) Q1 2025 Earnings Call
May 14, 2025 · Replay with transcript and chapters
Research Immunovia Ab
Alternate listings
IMMNOV:OMXSTO
SE · SEK
Alternate listing for Immunovia Ab; the primary context on this page is 1YR:MUN.
1YR:GETTEX
DE · EUR
Alternate listing for Immunovia Ab; the primary context on this page is 1YR:MUN.
0G8X:LSE
GB · SEK
Alternate listing for Immunovia Ab; the primary context on this page is 1YR:MUN.
IMMNOS:AQUISEU
GB · SEK
Alternate listing for Immunovia Ab; the primary context on this page is 1YR:MUN.
IMMNOS:AQUISUK
GB · SEK
Alternate listing for Immunovia Ab; the primary context on this page is 1YR:MUN.
1YR:FWB
DE · EUR
Alternate listing for Immunovia Ab; the primary context on this page is 1YR:MUN.
IMMVF:OTC
US · USD
Alternate listing for Immunovia Ab; the primary context on this page is 1YR:MUN.